Potrero Medical

What Potrero Medical does

Potrero Medical, Inc. is a privately-held medical device company headquartered in Hayward, California, founded in 2012 and operating commercially under the Accuryn Medical brand. The company develops the Accuryn Monitoring System, a smart catheter platform that transforms standard Foley catheters into intelligent medical devices capable of continuously monitoring urine output and intra-abdominal pressure in real time. The system's core clinical differentiator is a predictive algorithm clinically validated to detect acute kidney injury (AKI) in cardiac surgery patients approximately 33.6 hours before standard-of-care detection, as documented in peer-reviewed publications. Additional applications include intra-abdominal compartment syndrome monitoring and reduction of catheter-associated urinary tract infections (CAUTI) in burn centers and pediatric ICUs.

The underlying technology integrates proprietary hardware (the Accuryn SmartFoley catheter and Foley catheter tray) with a monitoring software platform that automates clinical data capture, visualizes patient trends, and enables earlier clinical interventions. The company monetizes through a combined hardware sales model (single-use catheters sold to hospitals) and a subscription-based monitoring platform, with revenue generated through an enterprise field sales motion targeting hospital procurement and clinical leadership in critical care settings including ICUs, cardiac surgery units, and burn centers. GTM assets include dedicated Request a Demo and Request a Quote workflows, a Knowledge Hub with peer-reviewed publications, and clinical expert endorsements from academic medical centers such as the University of Michigan.

The company has raised approximately $82.4 million across eight funding rounds since 2014, with named investors including GT Healthcare Capital Partners, Sonder Capital, and Green Park & Golf Ventures. Operations are US-only, the company maintains 11–50 employees, and recent SEC Form D filings in 2024, 2025, and 2026 indicate active ongoing capital deployment. Leadership includes a full C-suite (CEO Joe Urban, Founder/Chairman Daniel Burnett, CFO Jeff Mack, COO Sanjay Banerjee, CTO Saheel Sutaria, CMO Vanessa Mill, CSO Rebecca Lin, CCO Steve Okland) with recent additions of a Director of Growth and VP of R&D reflecting a transition toward commercial scaling.

Name

Potrero Medical

Legal name

Potrero Medical, Inc.

Website

https://potreromed.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Potrero Medical (operating as Accuryn Medical) is a privately-held medical device company that has developed the Accuryn Monitoring System, a smart Foley catheter platform providing continuous urine output and intra-abdominal pressure monitoring to predict acute kidney injury in hospital critical care units, targeting ICUs, cardiac surgery, and burn centers.

Ownership category

akta.pro rank

Product category

Critical Care Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Urinary Catheters & Drainage (Intermittent/Foley Catheters, Bags, Securement) (HLAHALAI)

akta.pro secondary industries

Renal Diagnostics & Monitoring (eGFR/Creatinine POC, Urine Analyzers, BP/Fluid Status) (HLAHAKAJ), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)

Keywords

• Critical care medical devices
• Smart catheter systems
• Acute kidney injury detection
• Patient monitoring platforms
• Intra-abdominal pressure monitoring

Headquarters

HQ city

Hayward

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Sales: Sale of Accuryn SmartFoley catheters and monitoring hardware to healthcare facilities. The product is a medical device that transforms traditional catheters into smart monitoring devices.
2. Monitoring Platform/Subscription: Software and monitoring platform services that provide real-time data visualization and predictive analytics for patient outcomes

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Potrero Medical (doing business as Accuryn Medical) manufactures the Accuryn SmartFoley catheter and the Accuryn Monitoring System, a smart catheter platform that continuously monitors real-time urine output and intra-abdominal pressure in critically ill patients. The platform enables early detection of acute kidney injury (AKI) and intra-abdominal hypertension, supporting clinical decision-making in ICU, cardiac surgery, and burn care settings.

Product overview

Potrero Medical (operating as Accuryn Medical) offers the Accuryn Monitoring System as its core product platform. The system comprises the Accuryn SmartFoley catheter hardware and a monitoring software platform that work together to provide real-time predictive health monitoring. The platform transforms traditional Foley catheters into smart devices that automate clinical data capture, visualize patterns, and enable earlier interventions for acute kidney injury prevention in critically ill patients.

Differentiator

Problem solved

Functional benefit

Brands

• Accuryn Monitoring System: A next-generation smart Foley catheter device and monitoring platform designed to predict acute kidney injury (AKI) and intra-abdominal compartment syndrome in critically ill patients.

Products and services

• Accuryn SmartFoley Catheter A smart Foley urinary catheter with integrated sensors that continuously, in real time, measure urine output and intra-abdominal pressure in critically ill patients. It is sold to hospitals for use in ICU, cardiac surgery, and burn care settings to support earlier detection of acute kidney injury (AKI) and intra-abdominal hypertension.
• Accuryn Monitoring System A proprietary software/hardware monitoring platform that pairs with the Accuryn SmartFoley catheter to continuously display real-time urine output and intra-abdominal pressure data at the bedside. The system enables clinicians to detect acute kidney injury (AKI) up to 33.6 hours earlier than standard of care, supporting clinical decision-making in ICU, cardiac surgery, and burn units.

Quantifiable outcome

• Detects acute kidney injury 33.6 hours before standard of care in cardiac surgery patients
• +2 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• ConvaTec: ConvaTec manufactures catheters, continence care, and ostomy products for hospital and home use. Its catheter portfolio overlaps with Potrero's core urological device, and the company is a relevant comparable in the consumable urinary catheter space.
• Medtronic: Medtronic is a global medical device leader with a broad portfolio including urinary catheters, patient monitoring systems, and critical care solutions. It overlaps with Potrero across Foley catheters and ICU monitoring, though it does not currently offer a dedicated smart AKI catheter.
• Baxter International: Baxter is a major player in renal care through its Vantive kidney-care business (formerly renal therapies) and produces a broad range of hospital medical devices. It shares Potrero's hospital critical care customer base and adjacent renal therapy focus.
• Edwards Lifesciences: Edwards Lifesciences is a leader in hemodynamic and critical care monitoring with its FloTrac, ClearSight, and related platforms. Its established presence in cardiac surgery and ICU monitoring makes it an adjacent incumbent whose data platforms could integrate with or compete against Accuryn.
• GE HealthCare: GE HealthCare provides patient monitoring solutions (e.g., CARESCAPE) widely used in ICUs and surgical suites. Its installed base of hospital monitoring infrastructure makes it a strategic comparable and potential partner or competitor in the ICU predictive monitoring space.
• Fresenius Medical Care: Fresenius is the world's largest provider of dialysis products and services, focused on end-stage renal disease and chronic kidney care. It addresses the broader kidney-care continuum overlapping with Potrero's AKI focus.
• Becton, Dickinson and Company (BD): BD is one of the largest manufacturers of Foley catheters and urological care products globally through its BD Medical segment. It serves the same hospital customers and could plausibly extend into smart catheter technology, making it a key incumbent peer for Potrero.

Emerging players

• Outset Medical: Outset Medical produces the Tablo hemodialysis system, bringing innovation to renal care delivery in hospitals and homes. It addresses the same kidney-care customer base as Potrero, though with a dialysis device rather than a monitoring catheter.

Regional players

• SteriCure (Coloplast): Coloplast is a global leader in ostomy, continence, and wound care, including intermittent catheters. While its catheter portfolio is more chronic-care oriented, it competes with Potrero's core urology product and serves overlapping clinical specialties.

Direct peers

• RenalSense: RenalSense develops Clarity RMS, a real-time urine output monitoring system for early AKI detection in ICU patients. It is the most direct competitor to Potrero's Accuryn, targeting the same clinical use case of automated, continuous kidney function monitoring in critical care.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@accurynmedical8399
• Xx.com/potreromedical
• Facebookfacebook.com/potreromed

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds8 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Potrero Medical